A Closer Look at the America Invents Act

January 6, 2012 | 1:41 PM


In this two-part presentation, Goodwin Procter partner Theresa Kavanaugh examines key provisions of the recently enacted Patent Reform Act, with a particular focus on how it may affect life science companies.

In part one, Kavanaugh discusses the new first-to-file system and new Prioritized Examination Procedure. In part two, she covers new opportunities to challenge third party patents under the new patent act. View the presentation here:

Part 1 >>

Part 2 >>

View the Client Alert >>